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Fibroblast growth receptors (FGFRs) consist of four signaling family members. Mice with deletions of fgfr1 or fgfr2 are embryonic lethal
prior to the onset of kidney development. To determine roles of FGFR1 and FGFR2 in the ureteric bud, we used a conditional targeting
approach. First, we generated transgenic mice using the Hoxb7 promoter to drive cre recombinase and green fluorescent protein expression
throughout ureteric bud tissue. We crossed Hoxb7creEGFP mice with mice carrying lox-p sites flanking critical regions of fgfr1 and/or fgfr2.
Absence of fgfr1 from the ureteric bud (fgfr1UB/) results in no apparent renal abnormalities. In contrast, fgfr2UB/ mice have very
aberrant ureteric bud branching, thin ureteric bud stalks, and fewer ureteric bud tips. Fgfr2UB/ ureteric bud tips also demonstrate
inappropriate regions of apoptosis and reduced proliferation. The nephrogenic mesenchymal lineage in fgfr2UB/ mice develops normal-
appearing glomeruli and tubules, and only slightly fewer nephrons than controls. In contrast, fgfr2UB/ kidneys have abnormally thickened
subcapsular cortical stromal mesenchyme. Ultimately, fgfr2UB/ adult kidneys are small and abnormally shaped or are hydronephrotic.
Finally, there are no additional abnormalities in the fgfr1/2UB/ kidneys versus the fgfr2UB/ kidneys. In conclusion, FGFR2, but not
FGFR1, appears crucial for ureteric bud branching morphogenesis and stromal mesenchyme patterning.
D 2004 Elsevier Inc. All rights reserved.
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Fibroblast growth factor receptors (FGFRs) are a gene
family of receptor tyrosine kinases with at least 4 signaling
members (Powers et al., 2000). Three of these genes (fgfrs1-3)
are capable of producing multiple receptor isoforms through
alternativesplicingofprimary transcripts (Powersetal., 2000).
Fibroblast growth factor receptors are activated by binding to
FGF ligands, of which there are 22 known family members in
mammals (Powers et al., 2000). Structurally, the receptors
consist ofup to threeexternal immunoglobulin-likedomains, a
transmembrane (TM) domain, and an intracellular kinase0012-1606/$ - see front matter D 2004 Elsevier Inc. All rights reserved.
doi:10.1016/j.ydbio.2004.09.002
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terminalportionof the third Ig-likedomainresults in IIIbor IIIc
isoforms, which have different ligand binding specificities
(Powers et al., 2000). In vitro, FGFR activation is associated
withmanybiological responses includingproliferation, differ-
entiation, migration, and inhibition of apoptosis (Klint and
Claesson-Welsh, 1999). Finally, fibroblast growth factor
receptors are expressed in many tissues of the developing
embryo starting prior to implantation and often persisting into
adulthood.
The metanephric kidney develops from 2 tissues arising
from the intermediate mesoderm, the Wolffian duct and the
nephrogenic cord (Kuure et al., 2000). Between gestational
ages 10.5–11.0 in the mouse, the nephrogenic cord gives
rise to the metanephric mesenchyme that then induces the
formation of the ureteric bud from the Wolffian duct in the
region of the hindlimb (Kuure et al., 2000). Shortly276 (2004) 403–415
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nephrogenic lineage lying adjacent to the ureteric bud, and
a stromal lineage that surrounds the nephrogenic mesen-
chyme (Kuure et al., 2000). The tissues then begin a series
of reciprocal inductive interactions, with the ureteric bud
receiving signals to branch dichotomously, ultimately to
form the collecting ducts and ureter (Kuure et al., 2000). At
each terminal tip, the ureteric bud induces local areas of
nephrogenic mesenchyme to differentiate into nephron
epithelia (Kuure et al., 2000). In addition to interactions
between the nephrogenic and ureteric bud lineage, others
have recently documented critical signaling between ure-
teric bud and stromal lineages (Batourina et al., 2001; de
Graaff et al., 2001; Mendelsohn et al., 1999).
Although several studies have reported finding fgfrs in
the developing mammalian kidney, the data on specific
expression patterns in the embryonic kidney are ambiguous
(Cancilla et al., 1999; Dudley et al., 1999; Fuhrmann et al.,
1999; Peters et al., 1992). One study in mice reported that
fgfr1 was present only in nephrogenic mesenchyme-derived
tissues by in situ hybridization (Peters et al., 1992). Another
report in rats, however, described fgfr1 expression in all
ureteric bud and nephrogenic mesenchymal lineages by in
situ hybridization and immunohistochemistry (Cancilla et
al., 1999). The studies on fgfr2 in rodents have all reported
expression in the ureteric bud, although there are disagree-
ments over the level and timing of expression in mesen-
chymal derivatives (Cancilla et al., 1999; Dudley et al.,
1999; Peters et al., 1992).
The importance of FGFR signaling in the developing
kidney was first demonstrated when transgenic mice with a
dominant negative FGFR fragment were found to possess
no kidneys or very small dysplastic kidney rudiments (Celli
et al., 1998). Despite this, gene targeting approaches have
only revealed limited data on which fgfrs are important in
the developing kidney. Mice with targeted deletions of fgfr1
die during or shortly gastrulation, prior to the onset of renal
development (Deng et al., 1994; Yamaguchi et al., 1994).
Although two groups reported different phenotypes in their
respective fgfr2 null mice, both strains were also embryonic
lethal before the kidney starts to form (Arman et al., 1998;
Xu et al., 1998). Mice with targeted deletions of fgfr3 and
fgfr4 are viable and do not have kidney abnormalities
(Colvin et al., 1996; Weinstein et al., 1998). Mice null for
fgf7, fgf10, and fgfr2-IIIb (the main receptor isoform for
FGF7 and FGF10), do have slightly small kidneys, but all
have normal-appearing nephrons (Ohuchi et al., 2000; Qiao
et al., 1999; Revest et al., 2001).
Our objective was to determine the roles of FGFR1 and
FGFR2 in the ureteric bud, using a conditional targetingFig. 1. Hoxb7creEGFP transgenic construct. Hoxb7 promoter (blue), cre recomb
green fluorescent protein (green), and human h globin poly-A tail (blue).approach. First, we generated transgenic mice using the
Hoxb7 promoter to drive expression of cre recombinase and
green fluorescent protein throughout ureteric bud tissue.
Then, we crossed Hoxb7creEGFP mice with mice carrying
lox-p sites flanking critical regions of fgfr1 and/or fgfr2.
Absence of fgfr1 from the ureteric bud results in no apparent
renal abnormalities. In contrast, fgfr2UB/ mice have thin
ureteric bud stalks, fewer total ureteric tips, and fewer tips
per surface area. Fgfr2UB/ ureteric tips also demonstrate
inappropriate regions of apoptosis and reduced proliferation.
The nephrogenic mesenchymal lineage in the fgfr2UB/
mice develops normal-appearing glomeruli and tubules, and
only slightly fewer nephrons than controls. In contrast, the
fgfr2UB/ kidneys have abnormally thickened cortical
stromal mesenchyme with excessive apoptosis. Ultimately,
fgfr2UB/ adult kidneys are small and abnormally shaped
or are hydronephrotic.Materials and methods
Generation of Hoxb7creEGFP mice and the conditional
knockout mice
We received a vector containing a portion of the Hoxb7
promoter (extending from 1316 to 181 of the genomic
fragment) followed by a 1.7-kb fragment of the human h
globin gene containing the polyadenylation (poly-A) signal
sequence (gift from Dr. Frank Costantini, Columbia Uni-
versity, New York). The Hoxb7 promoter fragment has been
used by others to misexpress genes such as an enhanced
green fluorescent protein (EGFP) (Srinivas et al., 1999a),
Ret (Srinivas et al., 1999b), and cre recombinase (Yu et al.,
2002). We then cloned in a cre recombinase open reading
frame (ORF) immediately downstream of the promoter
fragment followed by an internal ribosomal entry site
(IRES) and enhanced green fluorescent protein (EGFP)
ORF (derived from the pIRES2-EGFP vector from Clon-
tech/BD Biosciences) (see Fig. 1). After linearizing, we
injected the construct into mouse zygote pronuclei. We
identified three founder mice by polymerase chain reaction
(PCR) (see Table 1) followed by Southern blotting using the
fragment amplified from the PCR primers. We bred the
founder mice with FVB/N mice and confirmed genotypes in
the F1 offspring as above.
To characterize the expression of the three lines, we first
examined whole kidneys dissected at embryonic day (E)
14.5 under fluorescent light for the presence of GFP. We did
the same with explants dissected at E11.5 and grown for 3
days in Dulbecco’s modified Eagle medium (DMEM)inase open reading frame (yellow), internal ribosomal entry site, enhanced
Table 1
PCR primer constructs
Gene Primer pairs Size (BP)
Hoxb7cre
EGFP
5V-AGCGCGATCACA TGGTCCTG-3V 230
5V-ACGATCCTGAGACTTCCACACT-3V
fgfr1 5V-TTGACCGGATCTACACACACC-3V 602 (wt)
5V-AAGCCACCATCACCTGAGGAA-3V 672 (floxed)
fgfr2 5V-GTCAATTCTAAGCCACTGTCTGCC-3V 307 (wt)
5V-CTCCACTGATTACATCTAAAGAGC-3V 373 (floxed)
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test for cre recombinase activity, we bred the Hoxb7-
creEGFP lines with cre-responsive h-galactosidase reporter
mice (Gtrosa26tm1Sor) (Soriano, 1999). After fixing whole
E11.5 embryos overnight and E14.5 kidneys for 6 h with
4% paraformaldehyde (PFA) in phosphate-buffered saline
(PBS), we X-gal stained the tissues overnight at room
temperature with 5 mM potassium ferricyanide, 5 mM
potassium ferrocyanide, 4-chloro-5-bromo-3-indolyl-b-d-
galactopyranoside, 0.1% deoxycholate, 0.2% Nonidet P-
40, 2 mM MgCl2 in PBS. Two of the lines (5526 and 5530)
had specific expression in the ureteric bud epithelia and we
used the line with the strongest expression (5526) for all
subsequent studies.
To generate the conditional fgfr knockouts, we first
obtained mice with lox-p sites flanking critical regions
(floxed) of fgfr1 (gift from Dr. Janet Rossant, Samuel
Lunenfeld Research Institute, Toronto, Canada (Hebert et
al., 2003) and fgfr2 (gift from Dr. David Ornitz, Washington
University, St. Louis (Yu et al., 2003). Genotyping for the
fgfr1 and fgfr2 alleles were by PCR (see Table 1). We then
bred the hemizygous Hoxb7creEGFP mice (cre+/) with
mice that were compound homozygous for the floxed fgfr1
and fgfr2 alleles (fgfr1lox/lox, fgfr2lox/lox). We then bred cre-
positive progeny (cre+/, fgfr1lox/+, fgfr2lox/+) back with
the compound homozygous parental mice (fgfr1lox/lox,
fgfr2lox/lox). Subsequent Hoxb7creEGFP-positive progeny
contained mice with deletion of fgfr1, fgfr2, or both fgfr1/2,
or that were compound heterozygotes (see Table 2).
Explant and whole kidney studies
We removed embryonic kidney rudiments at E11.5 and
cultured them on nucleopore filters floating on DMEM with
10% FBS at 378C for 3 days. We then photographed the
GFP-positive ureteric bud trees in littermate double hetero-
zygous, fgfr1UB/, fgfr2UB/, and fgfr1/2UB/ explants
and tabulated the mean number of ureteric bud tips for eachTable 2
Possible outcomes in progeny from (Hoxb7creEGFP+/, fgfr1lox/+, fgfr2lox/+)  (
fgfr1lox/lox, fgfr2lox/+ fgfr1lox/+, fgfr2lox/lox
Hoxcre+/ UB deletion of fgfr1
(fgfr1UB/)
UB deletion of fgfr2
(fgfr2UB/)
Hoxcre/ no deletion no deletion
UB = ureteric bud.group. To visualize the developing glomeruli, we also
performed whole mount immunofluorescence on methanol-
fixed littermate explants with a polyclonal antibody against
Wt1 (Santa Cruz) in the manner we described previously
(Bates et al., 2000). We tabulated the mean number of
glomeruli in the double heterozygous, fgfr1UB/,
fgfr2UB/, and fgfr1/2UB/ explants. We compared the
mean number of ureteric bud tips and glomeruli for 4 cre-
positive groups with a one-way analysis of variance
(ANOVA) (P b 0.05 was considered significant). We also
compared mean numbers glomeruli in littermate double
heterozygous and cre-negative explants by unpaired T tests
(P b 0.05 was considered significant).
We removed and photographed kidneys from E13.5,
E16.5, and 6-week-old mice under direct light and tabulated
mean lengths of E16.5 littermate double heterozygous,
fgfr1UB/, fgfr2UB/, fgfr1/2UB/, and cre-negative
kidneys. We also photographed the embryonic kidneys
from the first four (cre-positive) groups under fluorescent
light to visualize the GFP-positive ureteric bud trees. We
also performed confocal microscopy on the cre-positive
E16.5 kidneys, capturing a total of thirty 10-Am-thick
sections/per kidney that were then compressed into a single
image. We compared the mean length, number of ureteric
bud tips and number of ureteric tips/surface area of each of
the 4 cre-positive groups a one-way analysis of variance
(ANOVA) (P b 0.05 was considered significant). We also
compared mean lengths of double heterozygous and cre-
negative explants by unpaired t tests (P b 0.05 was
considered significant).
Histological experiments on tissue sections
We performed hematoxylin and eosin (H&E) staining on
PFA-fixed, paraffin embedded E13.5, E16.5, and adult
kidney tissues from littermate double heterozygous,
fgfr1UB/, fgfr2UB/, fgfr1/2UB/, and cre-negative
mice (reagents from Richard-Allen Scientific). We also
performed immunofluorescence on Histochoice (Amresco)-
fixed, cryostat-sectioned E13.5 and E16.5 littermate kidney
sections with primary rabbit polyclonal antibodies against
FGFR1 (Santa Cruz, catalog #sc-121), FGFR2 (Santa Cruz,
catalog #sc-122), Wt1 (Santa Cruz, catalog #sc-192) and
GFP (Molecular Probes, catalog #A-11122) at 1:100, 1:100,
1:20, and 1 Ag/mL, respectively. We used secondary
antibodies including goat anti-rabbit Cyanine (Cy) 2
conjugates (for the GFP antibody) (Jackson Immunochem-
icals) and anti-rabbit Cy3 conjugates (for the other primaryfgfr1lox/lox, fgfr2lox/lox)
fgfr1lox/lox, fgfr2lox/lox fgfr1lox/+, fgfr2lox/+
UB deletion of fgfr1 and 2
(fgfr1/2UB/)
double heterozygotes
no deletion no deletion
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500, respectively. We performed immunofluorescence as we
described previously (Bates et al., 2003).
We performed radioactive in situ hybridization in PFA-
fixed, paraffin embedded E13.5 and E16.5 littermate kidney
sections using cDNA templates against fgfr1 (nucleotides
1546–1996 of GenBank accession no. NM010206) and
fgfr2 (nucleotides 1594–1941 of GenBank accession no.
X55441). The cDNA templates contain sequence of exons
that should be deleted in the conditional knockout mice
(Hebert et al., 2003; Yu et al., 2003). We generated 35S-
UTP-labeled antisense RNA probes against the cDNA
templates and performed in situ hybridization with the
probes as we described previously (Bates et al., 1997).
We performed non-radioactive in situ hybridization in
E13.5 littermate kidney sections using cDNA templates
against Foxd1 (nucleotides 1693–2690 of GenBank
accession no. L38607) (gift from Dr. Larry Patterson,
University of Cincinnati, Cincinnati, Ohio) and Ret (nucleo-
tides 3205–3688 of GenBank accession no. BC059012). We
generated digoxigenin-UTP-labeled antisense RNA probes
using the DIG RNA labeling kit (Roche). After de-
paraffinizing the sections, we hydrated, fixed with 4%
PFA for 30 min, treated with 0.2 N HCl for 5 min, and then
digested with 20 Ag/mL of proteinase K (Invitrogen) at
378C for 10 min. We then post fixed in 4% PFA for 10 min,
treated with 0.1 M triethanolamine freshly supplemented
with 625/250 mL of acetic anhydride for 10 min with
stirring, and dehydrated the sections. After the slides dried,
we added denatured probe diluted to 2 Ag/mL in hybrid-
ization buffer (Sigma) with 100 Ag/mL tRNA to slides,
applied coverslips, and incubated overnight at 558C in
humidifying chambers. We washed the tissues with 5 SSC
and then 2 SSC in 10 mM DTT at 508C for 30 min each.
We then incubated sections for 30 min with 20 Ag/mL
RNAse A and 100 U/mL of RNAse T1 at 378C. We then
blocked for 30 min in a solution of MAB (100 mM maleic
acid, 150 mM NaCl pH 7.5) containing 0.1% Tween and
2 mM levamisole. We then incubated with an anti-DIG
antibody (Roche) diluted 1:2000 in MAB over night at
48C. After three 10-min washes of MAB with 0.1%
Tween, we washed the sections twice for 5 min with AP
development buffer (10 mM Tris–Cl pH 9.5, 2 mM
levamisole, 500 mM NaCl, 0.1% Tween-20, 5 mM
MgCl2). We then placed the slides in a humidity chamber
and incubated them in BM purple AP substrate solution
(Roche) for 1 week. After stopping the reaction with three
5-min PBS washes, we dehydrated, clarified, and added
coverslips with aqueous mounting media. For the Foxd1
samples, we also counterstained with nuclear fast red prior
to dehydrating the sections.
We performed apoptosis and proliferation assays in
double heterozygous and fgfr2UB/ littermate embryonic
kidney sections. To detect apoptosis in E13.5 and E16.5
PFA-fixed, paraffin-embedded sections, we used the
Fluorescent FragEl DNA Fragmentation Detection kit(Oncogene). Briefly, we deparaffinized, hydrated, and
permeabilized the tissues with proteinase K. We then
incubated the sections with terminal transferase (TdT)
equilibration buffer for 30 min followed by the labeling
reaction mixture with TDT enzyme for 1 h at 378C. We
then washed the slides and added coverslips with aqueous
mounting media. To measure cell proliferation, we
performed bromodeoxyuridine (BrdU) assays on Histo-
choice-fixed, paraffin-embedded E13.5 kidney sections, as
exactly described previously (Bates et al., 2000). To
quantitate ureteric bud proliferation rates in the cortex,
we serially sectioned 6 fgfr2UB/ and 6 control littermates
(6 Am sections). On average, we stained every 10th
fgfr2UB/ section and every 12th control section for
BrdU as above (5 sections total). We then counted
numbers of BrdU-positive (brown) and -negative (blue)
cells in the ureteric bud tissues throughout the cortex in
one kidney per embryo. On average, we counted 531
fgfr2UB/ ureteric bud cells and 865 control ureteric bud
cells. We calculated proliferation rates in ureteric bud tips
from the ratio of BrdU-positive to total nuclei. We then
compared percentages of proliferation with unpaired t tests
with a P b 0.05 considered significant (as described
previously) (Bates et al., 2000).
Adult kidney glomerular counts
We determined glomerular number in double hetero-
zygous and fgfr2UB/ 6-week-old littermate mouse
kidneys using a variation of the technique of Damadian
et al. (1965) with significant modifications (Bankir and
Hollenberg, 1983; Gilbert et al., 1987) as we recently
described (Ortiz et al., 2001, 2003). We anesthetized the
mice with 0.1–0.15 mg/g body weight of Inactin and then
opened the chest to expose the heart. We infused 2 mL of a
1.25% solution of Alcian blue (Aldrich Chemical Com-
pany) in normal saline over 1 min into the left ventricle to
stain glomeruli (Bankir and Hollenberg, 1983; Gilbert et
al., 1987; Ortiz et al., 2001, 2003). After removing the
kidneys, we sliced them in half, and incubated in 5 cc of
27% ammonium hydroxide for 2 h at room temperature.
We then treated the kidneys with 5 mL of 8 N HCl at 508C
for 1 h. We diluted the suspension to a final volume of
20 mL with water and incubated overnight at 48C. We
counted the number of glomeruli in ten 30 AL samples using
a light microscope and tabulated the mean number of
glomeruli per kidney. We then compared mean glomerular
numbers with unpaired t tests (P b 0.05 was considered
significant).
Microscopy and photography
We captured all images on a MagnaFire digital camera
(Optronics) mounted on a Leica DM LB microscope and
then converted them to Adobe Photoshop files. We used a
Zeiss LSM 410 microscope for the confocal studies.
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Characterizing Hoxb7creEGFP mice and generation of
fgfr1 and fgfr2 conditional knockouts in the ureteric bud
To characterize the Hoxb7creEGFP mice, we first
examined embryonic tissues directly for GFP expression.
We detected specific GFP signal in the ureteric bud epithelia
in E11.5 explants (Fig. 2b) and in E14.5 whole kidneys (Fig.
2d). To confirm that the cre recombinase was active and to
evaluate transgene expression elsewhere in the embryo, we
then bred the transgenic mice with cre-responsive h-
galactosidase reporter mice. After X-gal staining, we
detected h-galactosidase in E11.5 embryonic ureteric buds
(Figs. 2f, g, arrows) and Wolffian ducts (Fig. 2g, concave
arrow) and in isolated embryonic kidney ureteric bud
epithelia (Fig. 2i). We also detected transgene expression
in the hindbrain regions of the embryos (Fig. 2f, arrow-
head), as is the case in other transgenic mice with the Hoxb7
promoter (Dr. Frank Costantini and Dr. Andrew McMahon,
personal communications). We then crossed the Hoxb7-
creEGFP mice with floxed fgfr1 and/or fgfr2 mice,
according the breeding scheme outlined in Materials and
methods and Table 2. In overall appearance as well as in
assays including histological staining, kidney length, and
explant ureteric bud and glomerular counts, double hetero-
zygous mice were indistinguishable from cre-negative mice;
therefore, unless otherwise indicated, we used double
heterozygotes as controls in comparison with fgfr1UB/,
fgfr2UB/, and fgfr1/2UB/ mice.
To determine efficiency of fgfr deletion from the ureteric
bud in the conditional knockouts, we first determined
whether we could detect fgfr expression in control uretericFig. 2. GFP and cre expression patterns in the Hoxb7creEGFP transgenic mouse.
E11.5 kidney explants (b) and E14.5 kidneys (d) but not in cre-negative littermate
Hoxb7creEGFP mice (f, g) show X-gal staining in the ureteric bud (arrows), Wolff
negative littermates (e) show no signal. (h, i) Similarly, at E14.5 Gtrosa-positive/c
while Gtrosa-positive/cre-negative littermate kidneys (h) show no signal. (a,
magnifications).bud tissues in by immunostaining and/or in situ hybrid-
ization; if so, we would then compare fgfr expression in
control and fgfrUB/ mouse kidneys. By in situ hybrid-
ization and immunofluorescence for fgfr1 at E13.5 and
E16.5, we detected signal in regions of control double
heterozygous kidneys including tubules that did not appear
to be ureteric bud tissues (Fig. 3b and not shown).
Immunostaining in serial sections of E16.5 control kidneys
confirmed that FGFR1-expressing tubules (Fig. 3b, arrow-
head) were not GFP-positive ureteric bud epithelia (Fig. 3a,
arrows). In contrast, while fgfr2 expression by in situ
hybridization appeared in some control mesenchyme tis-
sues, especially those immediately adjacent to the ureteric
bud (Figs. 3c and d, concave arrowheads), the most intense
signal was in the ureteric bud epithelia (Figs. 3c and d,
concave arrows). In fgfr2UB/ conditional knockout mice,
the mesenchyme continued to express fgfr2 by in situ
hybridization (Figs. 3e and f, concave arrowheads); how-
ever, the ureteric bud signal was completely absent (Figs. 3e
and f, concave arrowheads). Thus, we confirmed that the
fgfr2UB/ conditional knockout had very efficient deletion
of fgfr2 in the ureteric bud epithelia.
Fgfr2UB/ embryonic kidneys are small and adult kidneys
are abnormally shaped or hydronephrotic, while fgfr1UB/
are normal
We dissected and examined embryonic and adult kidneys
for phenotypic abnormalities. At E13.5 (not shown) and
E16.5, fgfr2UB/ kidneys (Fig. 4c) and fgfr1/2UB/
kidneys (not shown) were smaller than control (Fig. 4a)
and fgfr1UB/ kidneys (Fig. 4b), although a fluorescent
GFP-positive ureteric bud tree was apparent in all genotypes(a–d) GFP is expressed in ureteric bud tissues in Hoxb7creEGFP-positive
explants (a) or E14.5 kidneys (c). (e–g) In E11.5 embryos, Gtrosa-positive/
ian duct (concave arrow), hindbrain (arrowhead), while Gtrosa-positive/cre-
re-positive kidneys show X-gal staining throughout the ureteric bud tree (i),
b = 40 magnifications; c, d, g–i = 25 magnifications; e, f = 10
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confirmed that mean sizes of both fgfr2UB/ (1.47 mm F
0.8, N = 12) and the fgfr1/2UB/(1.40 mm F 0.06, N = 14)
were smaller than control (2.09 mm F 0.07, N = 18) (P b
0.0001) and fgfr1UB/ kidneys (2.07 mmF 0.7, N = 8) (P b
0.0001). There were no statistical differences in mean
lengths of fgfr2UB/ and fgfr1/2UB/ kidneys or of
control and fgfr1UB/ kidneys. Although mice of all
genotypes are viable after birth, approximately 80% of the
fgfr2UB/ adult mice have small, abnormally shaped
kidneys (Fig. 4h) and the other 20% have hydronephrosis
(Fig. 4i) which occurs unilaterally or bilaterally. Similar
renal phenotypes are present in fgfr1/2UB/ mice (not
shown) and fgfr1UB/ kidneys are indistinguishable from
controls (not shown). Despite the abnormalities in their
kidneys, fgfr2UB/ and fgfr1/2UB/ live born mice do
not have any obvious external abnormalities and are the
same sizes as control and fgfr1UB/ mice through adult-
hood (not shown). In addition, among the 36 hoxb7creFig. 3. Fibroblast growth factor receptor 1 and 2 staining patterns in embryo
immunostaining in adjacent sections reveals that FGFR1-expressing tubules (b, ar
control E13.5 kidney section, brightfield (c) and darkfield (d) images show inten
arrows) and moderate signal in mesenchyme-derived tissues especially those surro
kidney section, brightfield (e) and darkfield (f) images demonstrate absence of fg
persistence of mesenchyme-derived signal including tissues surrounding the uretepositive adult mice (from the crosses outlined in Table 2),
17 are either double heterozygotes or fgfr1UB/ and the
other 19 are either fgfr2UB/ or fgfr1/2UB/. The exact
numbers of mice for each genotype are listed in Table 3.
Fgfr2UB/ mice have profound abnormalities in ureteric
bud development, while fgfr1UB/ mice are normal
To characterize any defects in the ureteric bud lineage in
the fgfr1UB/ and/or fgfr2UB/ mice, we examined GFP-
positive ureteric bud tissues in E11.5 explants and E16.5
kidneys. Fgfr1UB/ explants (Fig. 5b) were indistinguish-
able from controls (Fig. 5a). In contrast, fgfr2UB/ explants
had abnormally thin, long ureteric stalks and fewer
peripheral tips, with a range in phenotype severity (compare
Figs. 5c and d). Fgfr1/2UB/ explants appeared similar to
the fgfr2UB/ mutants (not shown). Quantitatively, mean
ureteric bud tip numbers between control (42.3 F 2.0) and
fgfr1UB/ (44.1 F 2.5) were statistically no different, asnic kidneys. (a, b) In a control Hoxb7creEGFP-positive E16.5 kidney,
rowhead) are not GFP-positive ureteric bud epithelia (a, arrows). (c, d) In a
se fgfr2 signal by in situ hybridization in ureteric bud epithelia (concave
unding the ureteric bud (concave arrowheads). (e, f) In an fgfr2UB/ E13.5
fr2 signal in the ureteric bud by in situ hybridization (concave arrows), but
ric bud (concave arrowheads). (All = 200 magnifications).
Fig. 4. Gross comparison between control, fgfr1UB/ and fgfr2UB/ kidneys. (a–c) Comparison of E16.5 control double heterozygous (a), fgfr1UB/ (b) and
fgfr2UB/ kidneys under direct light (c). (d–f) Comparison of the same E16.5 kidneys under fluorescent light revealing GFP-positive ureteric bud tissues. (g–i)
Adult (6 week) kidneys from a control mouse (g) and a littermate fgfr2UB/ mouse with a small, abnormally shaped kidney (h) and a hydronephrotic kidney
(i). White scale bar = 0.5 mm. Black scale bar = 0.5 cm.
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(22.8 F 2.3). However, both control and fgfr1UB/
explants had statistically higher mean ureteric bud tip
numbers than both fgfr2UB/ (P b 0.0001) and the fgfr1/
2UB/ explants (P b 0.0001) (Fig. 5e). Confocal analysis
of isolated E16.5 kidneys revealed very similar data with
dramatic decreases in mean ureteric bud tip numbers on the
surface of fgfr2UB/ (89.5 F 14.1) and fgfr1/2UB/
kidneys (98.2 F 13.4) compared with either control (271 F
15.4) (P b 0.0001) or fgfr1UB/ kidneys (260 F 24.2) (P b
0.0001) (Fig. 5f). Further analysis of E16.5 fgfr2UB/ (and
fgfr1/2UB/) kidneys revealed a range in ureteric bud
defects, including extremely small kidneys with large areas
devoid of ureteric tissues (Fig. 6b, arrowheads). Even in
mutants with less severe phenotypes, there appear to be
fewer ureteric bud tips per surface area of the kidneyTable 3
Distribution of genotypes among the adult live-born hoxb7cre+ mice (from
breeding scheme outlined in Table 2)
Genotype Double
heterozygous
fgfr1UB/ fgfr2UB/ fgfr1/2UB/
# mice 10 7 9 10(Fig. 4f). Confocal analysis of GFP-positive E16.5
kidneys confirmed that mean ureteric bud tip numbers/
surface area (mm2) in fgfr2UB/ (19.5 F 1.8) and fgfr1/
2UB/ (21.4 F 1.8) are reduced compared with control
(31.6 F 0.65) (P b 0.0001) and fgfr1UB/ (32.6 F 1.1)
(P b 0.0001) (Fig. 5c). Thus, fgfr2UB/ and fgfr1/2UB/
mice have profound defects in ureteric bud development.
We then determined if inappropriate apoptosis and/or a
reduction in proliferation contributes to the defects in
fgfr2UB/ ureteric bud branching. To assay for apoptosis,
we performed fluorescent TUNEL (Terminal Deoxynucleo-
tidyl Transferase-mediated dUTP Nick-End Labeling) assays
(Oncogene) on E13.5 (not shown) and E16.5 (Fig. 7)
paraffin embryonic sections through regions containing
kidneys. On every section examined, at least one or more
fgfr2UB/ ureteric bud tips had clusters of 2–3 apoptotic
nuclei (Fig. 7b, arrowhead). In contrast, the vast majority of
control ureteric bud tips had no apoptotic nuclei (Fig. 7a);
rarely, controls would have one apoptotic nucleus in ureteric
tips (not shown). To assay for proliferation, we injected the
peritoneum of pregnant E13.5 females with bromodeoxyur-
idine (BrdU) (Sigma) and then performed immunostaining
for BrdU on sections containing kidney. Control ureteric bud
Fig. 5. Comparison of ureteric bud branching and ureteric bud tip numbers in control, fgfr1UB/, fgfr2UB/, and fgfr1/2UB/ embryonic kidneys. (a–d)
Fluorescent micrographs of E11.5 explants demonstrating that control (a) and fgfr1UB/( b) are indistinguishable, while fgfr2UB/ explants (c, d) have thin,
long ureteric trunks and fewer ureteric bud tips, with a range of phenotype severity (a–d = 40 magnifications). (e) Bar graph of E11.5 explant ureteric bud tip
numbers, showing that control (N = 16) and fgfr1UB/ (N = 14) are both different than fgfr2UB/ (N = 8) (P b 0.0001) and fgfr1/2UB/ (N = 8) (P b
0.0001). (f) Bar graph of E16.5 kidney ureteric bud tip counts from confocal images, demonstrating that control (N = 18) and fgfr1UB/ (N = 8) are both
different than fgfr2UB/ (N = 12) (P b 0.0001) and fgfr1/2UB/ (N = 14). (P b 0.0001).
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BrdU-positive nuclei than fgfr2UB/ ureteric bud tips (Fig.
7d). Quantitatively, the mean percentage of BrdU uptake in
controls (58.7% F 0.9%) was greater than fgfr2UB/
ureteric bud tips (45.5% F 1.4%, P b 0.0001) (Fig. 7e).
Thus, fgfr2UB/ mice have inappropriate regions of
apoptosis and decreased rates of proliferation in ureteric
bud tips compared with controls.
Fgfr2UB/ mice develop normal-appearing nephrons,
although the numbers are reduced, while fgfr1UB/ are
normal
By hematoxylin and eosin (H&E) staining, fgfr2UB/
embryonic (Fig. 8) and adult kidneys (not shown) have
normal-appearing nephrogenic mesenchyme-derived glo-
meruli (arrowheads) and tubules, as is true in fgfr1UB/
and fgfr1/2UB/ mice (not shown). Immunostaining for
Wilm’s Tumor Antigen (Wt1) revealed normal glomerularpodocyte staining patterns in embryonic kidneys of all
genotypes, although the numbers of glomeruli appeared
reduced in the fgfr2UB/ and the fgfr1/2UB/ mice (not
shown). To quantify glomerular numbers, we grew E11.5
explants for 3 days and then performed whole mount
immunostaining for Wt1. As in embryonic kidneys,
fgfr2UB/(Fig. 9b) and fgfr1/2UB/ explants (not
shown) appeared to have slightly fewer glomeruli
compared to control (Fig. 9a) and fgfr1UB/(not shown).
The mean numbers of glomeruli in control (28.6 F 1.7)
and fgfr1UB/(30.1 F 1.4) explants were not statistically
different, as was the case with fgfr2UB/(22.3 F 1.03)
and fgfr1/2UB/ explants (20.6 F 1.4). However, both
control and fgfr1UB/ explants had statistically higher
mean glomerular numbers than both fgfr2UB/ and
fgfr1/2UB/ explants (all P b 0.0015) (Fig. 9c). To
determine if the reduction in fgfr2UB/ glomerular
number persisted into adulthood, we perfused 2-month-
old fgfr2UB/ mice and wild type littermates with
Fig. 6. Comparison of ureteric bud tip numbers/surface area in control, fgfr1UB/, fgfr2UB/, and fgfr1/2UB/ E16.5 kidneys. (a–b) Fluorescent
micrographs of E16.5 littermate kidneys showing that compared to controls (a), many fgfr2UB/ kidneys (b) have large areas devoid of ureteric bud tissues
(arrowheads). (Scale bar = 0.5 mm). (c) Bar graph of E16.5 kidney ureteric bud tip numbers/surface area from confocal images showing that control (N = 18)
and fgfr1UB/ (N = 8) are both different than fgfr2UB/ (N = 12) (P b 0.0001) and fgfr1/2UB/ (N = 14) (P b 0.0001).
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kidneys had approximately 24% fewer glomeruli than
wild type littermates (15948 F 1186 vs. 21015 F 1001,
respectively) (Fig. 9d); this decrease was strikingly
similar to the 22% decrease in fgfr2UB/ explant
glomerular number compared with control (Fig. 9c).
Thus, although the nephrogenic mesenchyme forms
normal structures in mice of all genotypes, absence ofFig. 7. Comparison of apoptosis pattern and proliferation rates in control and fgfr2
E16.5 kidneys demonstrating no apoptosis in control ureteric bud tips (a) and 3 apo
staining is non-specific). (c–d) Light micrographs in E13.5 kidneys showing m
fgfr2UB/ ureteric bud tip nuclei (d). (a–d = 400 magnifications). (e) Bar grap
percentage of BrdU uptake than fgfr2UB/ (N = 6) (P b 0.0001).fgfr2 from the ureteric bud does lead to slight decreases
in glomerular numbers.
Fgfr2UB/ mice have patterning abnormalities in cortical
stromal mesenchyme
We then determined if there were any defects in cortical
stromal patterning in the fgfr2UB/ mice. In situ hybrid-UB/ ureteric bud tips (dotted lines). (a–b) Fluorescent TUNEL assays in
ptotic green nuclei in an fgfr2UB/ ureteric bud tip (b, arrowhead). (Yellow
ore apparent BrdU labeling in control ureteric bud tip nuclei (c) than in
h demonstrating that E13.5 control ureteric bud tips (N = 6) have a higher
Fig. 8. Comparison of control and fgfr2UB/ developing nephrons by H and E staining. Light micrographs showing that E16.5 control (a) and fgfr2UB/ (b)
kidneys both have normal appearing glomeruli (arrowheads) and no tubular dysplasia (both = 40 magnifications).
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stroma in subcapsular regions (Fig. 10b, arrow) compared
with control kidneys (Fig. 10a, arrow) in E13.5 kidneys. In
addition, intercalated stripes of stromal cells seen in control
kidneys (Fig. 10, arrowhead) were virtually absent in
fgfr2UB/ kidneys (Fig. 10b). Fluorescent TUNEL assays
in E13.5 and E16.5 (not shown) kidneys revealed additional
abnormalities in mutant stroma with regions of massive
subcapsular apoptosis in fgfr2UB/ kidneys (Fig. 10d,
concave arrowheads) compared with the relatively minor
cortical apoptosis seen in controls (Fig. 10c, arrowhead).
Since similar stromal (and ureteric bud) patterning defects
are present in mice with deletion of the Ret9 isoform (de
Graaff et al., 2001) and in mice with interruptions in retinoicFig. 9. Comparison of glomerular numbers in control, fgfr1UB/, fgfr2UB/, a
E11.5 explants demonstrating that controls (a) have more glomeruli than fgfr2UB
numbers showing that control (N = 8) and fgfr1UB/ (N = 7) are both different th
fgfr2UB/ P = 0.0012; fgfr1UB/ vs. fgfr2UB/ P b 0.0005). (d) Bar graph
glomeruli fgfr2UB/ kidneys (N = 12) (P = 0.0031).acid signaling (which causes Ret downregulation) (Batour-
ina et al., 2001; Mendelsohn et al., 1999), we performed in
situ hybridization for Ret. As in the case of controls (Fig.
10e), fgfr2UB/ embryonic kidneys do express Ret in the
peripheral ureteric bud tips in E13.5 kidneys (Fig. 10f,
concave arrow). Thus, the fgfr2UB/ kidneys have pattern-
ing defects in cortical stroma as well as in ureteric bud
branching, although Ret expression is normal.Discussion
Fgfr2UB/ mice have profound defects in the ureteric
bud lineage, including aberrant branching, thin stalks, fewernd fgfr1/2UB/ kidneys. (a, b) Whole mount Wt1 immunofluorescence in
/ (b). (a, b = 40 magnifications). (c) Bar graph of explant glomerular
an fgfr1/2UB/ (N = 8) (P b 0.0005) and fgfr2UB/ (N = 14) (control vs.
demonstrating that in adult mice, wild type kidneys (N = 14) have more
Fig. 10. Comparison of cortical stromal patterning and Ret expression in control and fgfr2UB/ E13.5 kidneys. (a, b) Foxd1 in situ hybridization
demonstrating that controls have normal subcapsular cortical stromal thickness (a, arrow) and intercalated stripes of stroma (a, arrowhead) compared with
fgfr2UB/ kidneys that have aberrantly thickened subcapsular stroma (b, arrow) and absence of intercalated stripes of stroma (b). (c, d) Fluorescent TUNEL
images showing minimal apoptosis in cortical stroma of control kidneys (c, concave arrowhead), but regions of extensive apoptosis in subcapsular cortical
stroma in fgfr2UB/ kidneys (d, concave arrowhead). (e, f) In situ hybridization demonstrating normal Ret expression in control and fgfr2UB/ ureteric bud
tips. (All = 200 magnifications).
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ities are secondary, at least in part, to a reduction in
proliferation and inappropriate regions of apoptosis in
ureteric bud tips. The nephrogenic mesenchymal lineage
in the fgfr2UB/ mice is much less affected with normal-
appearing glomeruli and tubules, and only slightly fewer
nephrons than controls. Fgfr2UB/ kidneys also have
thickened stromal mesenchyme with abnormally high rates
of apoptosis. The fgfr1UB/ mice have no apparent renal
abnormalities, and there is no additive effect in the fgfr1/
2UB/ kidneys versus the fgfr2UB/ kidneys. Ultimately,
fgfr2UB/ adult kidneys are small and abnormally shaped
or are hydronephrotic.
Despite the abnormalities in the kidneys, the fgfr2UB/
and fgfr1/2UB/ post-natal mice appear healthy with
apparently normal Mendelian numbers in comparison with
the double heterozygous and fgfr1UB/ mice. One possible
explanation is that there are enough residual functioningnephrons in the receptor 2 mutants to avoid renal failure. In
support of this hypothesis, on average, both the embryonic
explant and adult fgfr2UB/ mouse kidneys have only
approximately a 24% decrease in glomerular number
compared with controls. It is also possible that the
fgfr2UB/ and fgfr1/2UB/ mice have not been aged long
enough to detect emerging renal failure in older mice.
Finally, perhaps a small subset of fgfr2UB/ and fgfr1/
2UB/ mice do die shortly after birth, but we have not
collected a large enough number of post-natal mice to
observe a deviation from the expected Mendelian numbers
among the four genotypes.
Unlike the fgfr2UB/, the fgfrUB/ mouse kidneys
appear normal. One possible explanation is that fgfr1 is not
expressed in the murine ureteric bud. Although a report in
the rat does describe fgfr1 mRNA and protein in the ureteric
bud (Cancilla et al., 1999), other published data finds that in
the mouse kidney, fgfr1 expression is confined to glomeruli
H. Zhao et al. / Developmental Biology 276 (2004) 403–415414and other mesenchyme-derived tissues (Peters et al., 1992).
Our profiling data by both in situ hybridization and
immunofluorescence supports that at least in the mouse,
that fgfr1 is not expressed in the ureteric bud. Although
another potential explanation for the normal fgfr1UB/
phenotype would be that fgfr1 is incompletely deleted in the
ureteric bud, the floxed fgfr1 mouse has been shown to
delete well with other cre lines (Hebert et al., 2003) and our
Hoxb7cre mouse efficiently deleted fgfr2 from the ureteric
bud in the fgfr2UB/ mouse (see Fig. 3e and f). Finally, a
third possibility is that FGFR1 is expressed in the mouse
ureteric bud (below the sensitivity of our detection assays)
but that deletion of the receptor from the ureteric bud does
not result in an obvious renal developmental abnormality.
Although fgfr2UB/ mice have many similar renal
defects as in mice with deletions of the fgfr2-IIIb receptor
isoform or of fgf ligands with high degrees of specificity
for FGFR2-IIIb (Ohuchi et al., 2000; Qiao et al., 1999;
Revest et al., 2001), we detected abnormalities in the
fgfr2UB/ mice not described in any of the latter
knockout mice. For example, although both fgfr2UB/
mice and fgf7 knockout mice have small kidneys with
fewer ureteric bud branches and slightly fewer nephrons
(Qiao et al., 1999), the very aberrant ureteric bud
branching, stromal patterning defects, and hydronephrosis
seen in adult kidneys was only observed in the fgfr2UB/
mice. Although mice with targeted deletions of fgfr2-IIIb
and fgf10 also have small kidneys, the very abnormal
ureteric bud branching and stromal patterning defects we
describe in the fgfr2UB/ mice were also not reported in
the former mice (Ohuchi et al., 2000; Revest et al., 2001)
(although hydronephrosis was also not reported in the
former mice, both fgfr2-IIIb and fgf10 knockout mice die
shortly after birth due to dysplastic lungs, so that
abnormalities in adult kidneys cannot be assessed). One
possibility is that FGFR2-IIIb is the active FGFR2 isoform
in the ureteric bud and that the additional renal devel-
opmental abnormalities were simply overlooked in the
other mutants. In support of this hypothesis, IIIb isoforms
of fibroblast growth factor receptors are generally
expressed in epithelial tissues, while IIIc isoforms are
found in mesenchymal tissues (Powers et al., 2000). In
addition, targeted deletion of fgfr2-IIIc results in viable
mice with bone and limb anomalies, but no obvious
defects in kidney development (Eswarakumar et al., 2002).
Another possibility is that differences in background
strains and therefore modifier genes result in different
phenotypic abnormalities in the fgfr2UB/ conditional
knockouts compared with the fgfr2-IIIb and the ligand
knockouts. A less likely possibility is that due to
redundancy of the FGFR2-IIIb and IIIc isoforms, deletion
of either alone results in a less severe (or absent)
phenotype in the kidney than when both isoforms are
removed, as would be the case in the fgfr2UB/ kidneys.
The mechanism by which FGFR2 signaling in the
ureteric bud affects both ureteric bud and stromal patterningis unknown. Interestingly, the renal phenotypes we detected
in the fgfr2UB/ mice are strikingly similar to abnormal-
ities in mice with targeted deletions of the Ret9 isoform (de
Graaff et al., 2001) or with perturbations of retinoic acid
receptor signaling from either vitamin A (precursor to
retinoic acid) deprivation (Batourina et al., 2001) or deletion
of both retinoic acid receptors (RAR) a and b2 (Mendelsohn
et al., 1999). Moreover, interruption of retinoic acid signal-
ing results in downregulation of Ret expression on the
ureteric bud, while forced expression of Ret in Rara/
Rarb2/ double knockout mice completely rescues the
ureteric bud and stromal patterning defects (Batourina et al.,
2001). Despite the similar renal developmental anomalies
between the fgfr2UB/ mice and the other mutant mice, the
presence of Ret in fgfr2UB/ kidneys strongly suggests that
FGFR2 signaling is not upstream of the retinoic acid/Ret
signaling loop. Whether FGFR2 activity or expression is
dependent on retinoic acid or Ret signaling is unknown.
Another interesting possibility, however, is that Ret and
FGFR2, both receptor tyrosine kinases that are expressed in
the ureteric bud and that share at least one major signaling
adapter molecule (Hadari et al., 2001; Melillo et al., 2001),
may have common downstream target(s) that mediate
ureteric bud and/or stromal patterning.Acknowledgments
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